Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 5, 2010, Pages 919-922

  Chen, Tseng Shing ^a   Luo, Jiing Chyuan ^a   Chang, Full Young ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Aspirin; Duodenal ulcer; Gastro duodenal ulcer; Helicobacter pylori; Non steroidal anti inflammatory drug

Indexed keywords

ACETYLSALICYLIC ACID; UREASE; ANTIINFECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; DISEASE ASSOCIATION; DUODENUM ULCER; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TAIWAN; UREA BREATH TEST; AGED; GROUPS BY AGE; HOSPITAL PATIENT; MASS SPECTROMETER; MEDICAL EXAMINATION; OUTPATIENT; PEPTIC ULCER; RAPID UREASE TEST; SEX DIFFERENCE; BREATH ANALYSIS; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; STOMACH ULCER;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREATH TESTS; CHI-SQUARE DISTRIBUTION; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROTON PUMP INHIBITORS; RISK ASSESSMENT; RISK FACTORS; STOMACH ULCER; TAIWAN;

EID: 77951711189     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06139.x     Document Type: Article

References (28)

1. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990 335 : 1233 1235. (Pubitemid 20181778)
2. Marshall BJ, Goodwin CS, Warren JR et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988 2 : 1437 1442.
3. Marshall BJ, McGechie DB, Rogers PA et al. Pyloric campylobacter infection and gastroduodenal disease. Med. J. Aust. 1985 142 : 439 444.
4. Borody TJ, George LL, Brandl S et al. Helicobacter pylori-negative duodenal ulcer. Am. J. Gastroenterol. 1991 86 : 1154 1157.
5. Chen TS, Chang FY, Lee SD. A single standard nocturnal dose of nizatidine enhances the healing of active duodenal ulcers among Chinese. J. Gastronterol. Hepatol. 1995 10 : 135 139.
6. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JBD. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am. J. Gastroenterol. 1999 94 : 1834 1840. (Pubitemid 29315895)
7. Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am. J. Gastroenterol. 1998 93 : 1409 1415. (Pubitemid 29075174)
8. Nishikawa K, Sugiyama T, Kato M et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur. J. Gastroenterol. Hepatol. 2000 12 : 635 640. (Pubitemid 30433538)
9. Sheu BS, Lee SC, Yang HB et al. Selection of lower cut-off point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy. Dig. Dis. Sci. 2000 45 : 1330 1336.
10. Yee YK, Chang KK, Li KF, Lee CK, Wong SW, Szeto ML. Decreasing prevalence of H. pylori infection in patients with peptic ulcer diseases. Gastroenterology 2000 118 : A728.
11. Arents NLA, Thijs JC, Van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8-year period. Eur. J. Gastroenterol. Hepatol. 2004 16 : 779 783.
12. Lin JT, Wang JT, Wang TH et al. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan. Scand. J. Gastroenterol. 1993 28 : 1067 1072.
13. Higuchi K, Arakawa T, Fujiwara Y et al. Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H. pylori infection in the general population? Am. J. Gastroenterol. 1999 94 : 3083 3084. (Pubitemid 29482798)
14. Arakawa T, Higuchi K, Fujiwara Y et al. Helicobacter pylori: criminal or innocent bystander? J. Gastroenterol. 2000 35 (Suppl. 12 42 6. (Pubitemid 30229717)
15. McColl KEL, El-Nujumi AM, Chittajallu RS et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993 34 : 762 768. (Pubitemid 23185100)
16. Hyvärinen H, Salmenkylä S, Sipponen P. Helicobacter pylori-Negative duodenal and pyloric ulcer: Role of NSAIDs. Digestion 1996 57 : 305 309. (Pubitemid 26300783)
17. Konturek SJ, Bielanski W, Plonka M et al. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastro-duodenal ulcers. Scand. J. Gastroenterol. 2003 38 : 923 930. (Pubitemid 37153619)
18. Lee HR, Han KS, Yoo BC, Park SM, Cha YJ. Prevalence of Helicobacter pylori infection in patients with peptic ulcer diseases and non-ulcer dyspepsia. Korean J. Intern. Med. 1993 8 : 73 7.
19. Chen TS, Chang FY, Lee SD. A biopsy urease test in the detection of Helicobacter pylori: Comparison of antral and body specimens. Chin. Med. J. 1995 55 : 361 365.
20. Chen TS, Chang FY. Clinical characteristics of Helicobacter pylori-negative duodenal ulcer disease. Hepatogastroenterology 2008 55 : 1615 1618.
21. Gisbert JP, Blanco M, Mateos JM et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig. Dis. Sci. 1999 44 : 2295 2302.
22. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am. J. Gastroenterol. 1998 93 : 574 578. (Pubitemid 29081005)
23. Nensey YW, Schubert TT, Bologna SD, Ma CK. Helicobacter pylori-negative duodenal ulcer. Am. J. Med. 1991 91 : 15 18.
24. Bytzer P, Teglbjaerg PS, Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis - results from a randomized trial with 2-year follow-up. Am. J. Gastroenterol. 2001 96 : 1409 1416. (Pubitemid 32455067)
25. Chu KM, Kwok KF, Law S, Wong KH. Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics. World J. Gastroenterol. 2005 11 : 3518 3522. (Pubitemid 40903504)
26. Hansson LE, Nyren O, Hsing AW et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med. 1996 335 : 242 249. (Pubitemid 26249572)
27. Mihara M, Haruma K, Kamada T et al. The role of endoscopic findings for the diagnosis of Helicobacter pylori infection: evaluation in a country with high prevalence of atrophic gastritis. Helicobacter 1999 4 : 40 8. (Pubitemid 129688327)
28. Genta RM, Robason GO, Graham DY. Inflammatory responses and intensity of Helicobacter pylori infection in patients with duodenal and gastric ulcer: histopathologic analysis with a new stain. Acta Histochem. Cytochem. 1995 28 : 67 72.